This finding is in accordance with our experimental evidence that PDGF-driven gliomas can originate in the SVZ, cortex and cerebellum if PDGF overexpression together with INK4A/ARF loss is engineered into the murine brain. Here, CDKN2A is linked to central nervous system cancer.